These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15055521)

  • 21. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cdk5 mediates changes in morphology and promotes apoptosis of astrocytoma cells in response to heat shock.
    Gao C; Negash S; Wang HS; Ledee D; Guo H; Russell P; Zelenka P
    J Cell Sci; 2001 Mar; 114(Pt 6):1145-53. PubMed ID: 11228158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos.
    Zhu Y; Lin L; Kim S; Quaglino D; Lockshin RA; Zakeri Z
    Cell Death Differ; 2002 Apr; 9(4):421-30. PubMed ID: 11965495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A; Saito T; Hisanaga S
    J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
    Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
    J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of nuclear import mechanisms for the neuronal Cdk5 activator.
    Fu X; Choi YK; Qu D; Yu Y; Cheung NS; Qi RZ
    J Biol Chem; 2006 Dec; 281(51):39014-21. PubMed ID: 17060323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.
    Hamdane M; Bretteville A; Sambo AV; Schindowski K; Bégard S; Delacourte A; Bertrand P; Buée L
    J Cell Sci; 2005 Mar; 118(Pt 6):1291-8. PubMed ID: 15741232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction.
    Fu AK; Fu WY; Cheung J; Tsim KW; Ip FC; Wang JH; Ip NY
    Nat Neurosci; 2001 Apr; 4(4):374-81. PubMed ID: 11276227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.
    Zheng M; Leung CL; Liem RK
    J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic.
    Paglini G; Peris L; Diez-Guerra J; Quiroga S; Cáceres A
    EMBO Rep; 2001 Dec; 2(12):1139-44. PubMed ID: 11743029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer dense fibers serve as a functional target for Cdk5.p35 in the developing sperm tail.
    Rosales JL; Lee BC; Modarressi M; Sarker KP; Lee KY; Jeong YG; Oko R; Lee KY
    J Biol Chem; 2004 Jan; 279(2):1224-32. PubMed ID: 14581463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology.
    Griffin SV; Hiromura K; Pippin J; Petermann AT; Blonski MJ; Krofft R; Takahashi S; Kulkarni AB; Shankland SJ
    Am J Pathol; 2004 Oct; 165(4):1175-85. PubMed ID: 15466384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
    Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
    J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
    Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
    J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
    Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
    J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes.
    Nakano N; Nakao A; Ishidoh K; Tsuboi R; Kominami E; Okumura K; Ogawa H
    Br J Dermatol; 2005 Jul; 153(1):37-45. PubMed ID: 16029324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.
    Peterson DW; Ando DM; Taketa DA; Zhou H; Dahlquist FW; Lew J
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2884-9. PubMed ID: 20133653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.